Eton Pharmaceuticals, Inc. ETON Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $86.93M+8.7% | $79.95M+13.7% | $70.32M+20.9% | $58.18M+20.4% | $48.33M+23.9% | ||
| $39.32M+5.7% | $37.21M+8.8% | $34.2M+44.8% | $23.62M+17.7% | $20.06M+28.6% | ||
| $47.61M+11.4% | $42.74M+18.3% | $36.12M+4.5% | $34.56M+22.3% | $28.27M+20.7% | ||
| 54.8%+1.3pp | 53.5%+2.1pp | 51.4%-8.0pp | 59.4%+0.9pp | 58.5%-1.5pp | ||
| $8.48M+9.2% | $7.77M— | —— | —— | —— | ||
| $37.1M+3.6% | $35.82M+6.3% | $33.68M+9.1% | $30.86M+15.3% | $26.77M+17.6% | ||
| $45.57M+4.6% | $43.58M+12.3% | $38.8M+9.7% | $35.37M+15.8% | $30.53M+17.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | -$6.48M-61.0% | -$4.03M+10.4% | -$4.5M-18.0% | ||
| —— | —— | $199K+97.0% | $101K+13.5% | $89K+493% | ||
| —— | —— | -$6.68M-61.9% | -$4.13M+9.9% | -$4.58M-19.9% | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s revenue?
- Eton Pharmaceuticals, Inc. (ETON) generated $86.9M in revenue over the trailing twelve months, up 79.9% year over year.
- Is Eton Pharmaceuticals, Inc. profitable?
- Eton Pharmaceuticals, Inc. is not currently profitable: it reported a net loss of $4.5M over the trailing twelve months, a -9.5% net margin.
- What are Eton Pharmaceuticals, Inc.'s profit margins?
- Gross margin is 54.8% and operating margin is -15.1%, with a -9.5% net margin.
- What is Eton Pharmaceuticals, Inc.'s earnings per share?
- Eton Pharmaceuticals, Inc.'s diluted EPS over the trailing twelve months is $-0.06.
- Where does Eton Pharmaceuticals, Inc.'s income statement data come from?
- Every line is extracted from Eton Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
